Insights from patients who have participated, or who have considered participating, in clinical trials tells us that giving patients the Informed Consent Form (ICF) to read and sign, is not enough to overcome the potential barriers they face. These barriers are amplified in diverse populations due to factors like the lack of diverse physicians, historical mistrust, and information not translated or culturally adapted.